Amogh Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 2.00 Cr
- Paid Up Capital ₹ 1.49 Cr
- Company Age 32 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 5.81 Cr
- Satisfied Charges ₹ 2.17 M
- Revenue Growth 13.93%
- Profit Growth -19.12%
- Ebitda -66.61%
- Net Worth 46.17%
- Total Assets 28.01%
About Amogh Pharmaceuticals
Amogh Pharmaceuticals Private Limited (APPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 05 June 1992 and has a history of 32 years and eight months. Its registered office is in Delhi, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.00 Cr and a paid-up capital of Rs 1.49 Cr.
The company currently has active open charges totaling ₹5.81 Cr. The company has closed loans amounting to ₹2.17 M, as per Ministry of Corporate Affairs (MCA) records.
Jai Singh and Avinash Sharma serve as directors at the Company.
Company Details
- Location
Delhi, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U74899DL1992PTC049080
- Company No.
049080
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
05 Jun 1992
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Amogh Pharmaceuticals?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Jai Singh  | Director | 05-Jun-1992 | Current |
| Avinash Sharma | Director | 05-Jun-1992 | Current |
Financial Performance of Amogh Pharmaceuticals.
Amogh Pharmaceuticals Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 13.93% increase. The company also saw a substantial fall in profitability, with a 19.12% decrease in profit. The company's net worth Soared by an impressive increase of 46.17%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Amogh Pharmaceuticals?
In 2021, Amogh Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹5.81 Cr
₹0.22 Cr
Charges Breakdown by Lending Institutions
- Sidbi : 4.35 Cr
- Others : 1.20 Cr
- Hdfc Bank Limited : 0.19 Cr
- Bank Of Baroda : 0.07 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 19 Jul 2024 | Sidbi | ₹1.10 M | Open |
| 11 Mar 2024 | Sidbi | ₹5.00 M | Open |
| 10 Nov 2023 | Hdfc Bank Limited | ₹1.05 M | Open |
| 17 Jun 2023 | Others | ₹0.68 M | Open |
| 06 Jun 2023 | Sidbi | ₹1.00 Cr | Open |
How Many Employees Work at Amogh Pharmaceuticals?
Unlock and access historical data on people associated with Amogh Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Amogh Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Amogh Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.